Literature DB >> 10709969

Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo.

A Espinar1, A García-Oliva, E M Isorna, A Quesada, F A Prada, J M Guerrero.   

Abstract

This work investigated the ability of melatonin to prevent cell damage in the cerebellar cortex of chick embryo caused by glutamate administration. Cell injury was evaluated estimating, at ultrastructural level, the phenomenon of cell death and the synaptogenesis of the Purkinje cells and the cerebellar glomerular synaptic complex. Administration of glutamate during cerebellar development of the chick provokes excitotoxic neuronal degeneration characterized by a phenomenon of neuronal cell death that exhibits essentially the features of a death pattern described as necrosis and the deletion of synaptogenic processes. Our results show that melatonin has a neuroprotective effect against glutamate-induced excitotoxicity. This effect is morphologically revealed by the lack of neural cell death in the embryos treated with melatonin prior to glutamate injection and also by the degree of a synaptogenesis similar to that exhibited by the control group. Likewise, we corroborate the absence of teratological effects of melatonin on chick cerebellar development. Although the possible mechanisms involved in the neuroprotective effect of melatonin are discussed, i.e., direct antioxidant effects, up-regulating endogenous antioxidant defenses, and inhibiting nitric oxide formation activated by glutamate, further studies are required to establish the actual mechanism involved in the neuroprotective effect of melatonin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709969     DOI: 10.1034/j.1600-079x.2001.280203.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  8 in total

1.  Possible role of pineal allopregnanolone in Purkinje cell survival.

Authors:  Shogo Haraguchi; Sakurako Hara; Takayoshi Ubuka; Masatoshi Mita; Kazuyoshi Tsutsui
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

Review 2.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

3.  A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes.

Authors:  Madhur Gupta; Yogendra Kumar Gupta; Sarita Agarwal; Satinder Aneja; Kamlesh Kohli
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests.

Authors:  N Chatterjie; G Alexander; H Wang
Journal:  Neurochem Res       Date:  2001-10       Impact factor: 3.996

Review 5.  Bench to cribside: the path for developing a neuroprotectant.

Authors:  Nelina Ramanantsoa; Bobbi Fleiss; Myriam Bouslama; Boris Matrot; Leslie Schwendimann; Charles Cohen-Salmon; Pierre Gressens; Jorge Gallego
Journal:  Transl Stroke Res       Date:  2012-12-21       Impact factor: 6.829

6.  Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptors involved?

Authors:  Andréa C Paula-Lima; Paulo Roberto Louzada; Fernando G De Mello; Sérgio T Ferreira
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.

Authors:  Sergio Rosales-Corral; Dario Acuna-Castroviejo; Dun Xian Tan; Gabriela López-Armas; José Cruz-Ramos; Rubén Munoz; Valery G Melnikov; Lucien C Manchester; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2012-05-13       Impact factor: 6.543

8.  Neuroprotective effects of melatonin and celecoxib against ethanol-induced neurodegeneration: a computational and pharmacological approach.

Authors:  Lina T Al Kury; Alam Zeb; Zain Ul Abidin; Nadeem Irshad; Imran Malik; Arooj Mohsin Alvi; Atif Ali Khan Khalil; Sareer Ahmad; Muhammad Faheem; Arif-Ullah Khan; Fawad Ali Shah; Shupeng Li
Journal:  Drug Des Devel Ther       Date:  2019-08-02       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.